Profil
Erik Johan Frostegård is the founder of Athera Biotechnologies AB, which was founded in 2002.
He held the title of Director at Athera Biotechnologies AB. Currently, Dr. Frostegård is the Head of the Immunology & Chronic Disease Department at Karolinska Institutet and a Senior Consultant at Karolinska University Hospital.
In the past, he was a Director at Annexin Pharmaceuticals AB.
Postes actifs de Erik Johan Frostegård
| Sociétés | Poste | Début |
|---|---|---|
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Karolinska University Hospital
Karolinska University Hospital Hospital/Nursing ManagementHealth Services Provides hospital services | Corporate Officer/Principal | - |
Anciens postes connus de Erik Johan Frostegård
| Sociétés | Poste | Fin |
|---|---|---|
| ANNEXIN PHARMACEUTICALS AB | Directeur/Membre du Conseil | - |
Athera Biotechnologies AB
Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Provides anti-inflammatory biological candidate drugs | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Athera Biotechnologies AB
Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Provides anti-inflammatory biological candidate drugs | Health Technology |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karolinska University Hospital
Karolinska University Hospital Hospital/Nursing ManagementHealth Services Provides hospital services | Health Services |
Annexin Pharmaceuticals AB
Annexin Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures drugs for cardiovascular diseases | Health Technology |
















